These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 643908)

  • 1. Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.
    Fuxe K; Fredholm BB; Agnati LF; Ogren SO; Everitt BJ; Jonsson G; Gustafsson JA
    Pharmacology; 1978; 16 Suppl 1():99-134. PubMed ID: 643908
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptor sensitivity in brain and retina of rats during aging.
    Govoni S; Loddo P; Spano PF; Trabucchi M
    Brain Res; 1977 Dec; 138(3):565-70. PubMed ID: 597726
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible anomalous behaviour of apomorphine in relation to other dopamine receptor agonists.
    Feenstra MG; Goedemoed JH; Rollema H; Horn AS
    J Pharm Pharmacol; 1983 Jul; 35(7):471-3. PubMed ID: 6136595
    [No Abstract]   [Full Text] [Related]  

  • 4. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic drugs and ovulation: studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats.
    Agnati L; Fuxe K; Löfstöm A; Hökfelt T
    Adv Biochem Psychopharmacol; 1977; 16():159-68. PubMed ID: 883540
    [No Abstract]   [Full Text] [Related]  

  • 6. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 7. Apomorphine: chemistry, pharmacology, biochemistry.
    Colpaert FC; Van Bever WF; Leysen JE
    Int Rev Neurobiol; 1976; 19():225-68. PubMed ID: 13044
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R; Horn A; Iversen L; Pinder R
    Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
    Menon MK; Clark WG; Masuoka DT
    Psychopharmacology (Berl); 1977 May; 52(3):291-7. PubMed ID: 406633
    [No Abstract]   [Full Text] [Related]  

  • 11. Supersensitivity after intraventricular 6-hydroxydopamine: relation to dopamine depletion.
    Zigmond MJ; Stricker EM
    Experientia; 1980 Apr; 36(4):436-8. PubMed ID: 7379917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K; Roberts S; Hill DF
    Nature; 1974 Dec; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthyroidism: specifically increased response to central NA-(alpha-)receptor stimulation and generally increased monoamine turnover in brain.
    Strömbom U; Svensson TH; Jackson DM; Engström G
    J Neural Transm; 1977; 41(1):73-92. PubMed ID: 915501
    [No Abstract]   [Full Text] [Related]  

  • 14. The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase.
    Green AR; Heal DJ; Grahame-Smith DG; Kelly PH
    Neuropharmacology; 1976 Oct; 15(10):591-9. PubMed ID: 825788
    [No Abstract]   [Full Text] [Related]  

  • 15. The relative importance of dopamine and norepinephrine in mediating locomotor activity.
    Fishman RH; Feigenbaum JJ; Yanai J; Klawans HL
    Prog Neurobiol; 1983; 20(1-2):55-88. PubMed ID: 6141594
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of ergot alkaloids with dopaminergic receptors in the rat striatum and nucleus accumbens.
    Spano PF; Trabucchi M
    Gerontology; 1978; 24 Suppl 1():106-14. PubMed ID: 618775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropharmacology of apomorphine (review of the literature)].
    Zharkovskiĭ AM; Allikmets LKh
    Farmakol Toksikol; 1981; 44(2):226-32. PubMed ID: 7023969
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the dopamine sensitive adenylate cyclase in the rat substantia nigra coupled with 'autoreceptors'?
    Premont J; Thierry AM; Tassin JP; Glowinski J; Blanc G; Bockaert J
    FEBS Lett; 1976 Sep; 68(1):99-104. PubMed ID: 964385
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
    Oelssner W
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged apomorphine-like behavioural effects of apomorphine esters.
    Borgman RJ
    Neuropharmacology; 1976 Aug; 15(8):471-8. PubMed ID: 988501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.